Tonix Pharmaceuticals Holding annual operating margin
2023
2024
2025
Tonix Pharmaceuticals Holding's operating margin was −959.05% for fiscal 2025.
View full Tonix Pharmaceuticals Holding company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −959.05% | +395.23 pp |
| 2024 | 2024-12-31 | −1,354.28% | +169.66 pp |
| 2023 | 2023-12-31 | −1,523.94% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −314.05% | +1102.17 pp |
| Q1 2026 | 2026-03-31 | −603.91% | +57.02 pp |
| Q4 2025 | 2025-12-31 | −895.84% | −25.20 pp |
| Q3 2025 | 2025-09-30 | −1,005.08% | −453.91 pp |
| Q2 2025 | 2025-06-30 | −1,416.22% | +2085.41 pp |
| Q1 2025 | 2025-03-31 | −660.93% | +199.30 pp |
| Q4 2024 | 2024-12-31 | −870.64% | −165.03 pp |
| Q3 2024 | 2024-09-30 | −551.17% | — |
| Q2 2024 | 2024-06-30 | −3,501.63% | — |
| Q1 2024 | 2024-03-31 | −860.23% | — |
| Q3 2023 | 2023-09-30 | −705.62% | — |
Across the available reported history, Tonix Pharmaceuticals Holding's operating margin increased from −1,354.28% to −959.05%, a change of +395.23 percentage points. The latest reported quarter, Q2 2026, shows −314.05%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tonix Pharmaceuticals Holding filings at SEC.gov ↗